1
|
Albertsen A. Unjust organ markets and why it is irrelevant that selling a kidney is the best option. JOURNAL OF MEDICAL ETHICS 2024:jme-2023-109593. [PMID: 38806229 DOI: 10.1136/jme-2023-109593] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/19/2023] [Accepted: 04/17/2024] [Indexed: 05/30/2024]
Abstract
An important argument against prohibiting organ sales is that it removes the best option available to individuals in dire circumstances. However, this line of reasoning fails to recognise that selling a kidney on a regulated market is only the best option in a very narrow comparison, where a regulated organ market is compared with banning organ sales. Once we acknowledge this narrowness, selling a kidney is not the best option. This paves the way for a distributive justice-based critique of the 'best option' argument for organ markets, which illuminates that organ markets should be compared with a broader set of alternatives. If providing the option of selling a kidney is not the best option, but rather the best option we are willing to provide, and one which means that many people will remain in poverty and unjust circumstances, then this reflects poorly on those societies willing to offer only this option and not a better one.
Collapse
Affiliation(s)
- Andreas Albertsen
- Department of Political Science, School of Business and Social Sciences, Aarhus Universitet, Aarhus, Denmark
- The Centre for the Experimental-Philosophical Study of Discrimination-CEPDISC, Department of Political Science, Aarhus University, Aarhus, Denmark
| |
Collapse
|
2
|
Li MH, Yu Y, Siddique AB, Lee N, Haque MR, Rahman MLT, Ahmad M, El-Amine H, Koizumi N. Using the network scale-up method to characterise kidney trafficking in Kalai Upazila, Bangladesh. BMJ Glob Health 2023; 8:e012774. [PMID: 38035730 PMCID: PMC10689364 DOI: 10.1136/bmjgh-2023-012774] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2023] [Accepted: 10/16/2023] [Indexed: 12/02/2023] Open
Abstract
This study aimed to estimate the prevalence of illegal kidney sales in Kalai Upazila, Bangladesh, using the Network Scale-Up Method (NSUM), an ego-centric network survey-based technique used to estimate the size of hidden populations. The study estimated the size of the kidney seller population, analysed the profiles of kidney sellers and kidney brokers and investigated the characteristics of villagers who are more likely to be connected to kidney sellers to identify possible biases of the NSUM estimate. The study found that the prevalence of kidney trafficking in Kalai Upazila was between 1.98% and 2.84%, which is consistent with the estimates provided by a local leader and reporters, but with much narrower bounds. The study also found that a large proportion of kidney sellers and brokers were men (over 70% and 90%, respectively) and relatively young (mean age of 33 and 39, respectively). Specific reasons for kidney sales included poverty (83%), loan payment (4%), drug addiction (2%) and gambling (2%). While most reported male sellers were farmers (56%) and female sellers were housewives (78%) in need of money, most reported brokers were characterised as rich, well-known individuals.
Collapse
Affiliation(s)
- Meng-Hao Li
- Schar School of Policy and Government, George Mason University, Arlington, Virginia, USA
| | - Yang Yu
- Schar School of Policy and Government, George Mason University, Arlington, Virginia, USA
| | - Abu Bakkar Siddique
- School of Public Administration, Florida Atlantic University, Boca Raton, Florida, USA
| | - Narae Lee
- Schar School of Policy and Government, George Mason University, Arlington, Virginia, USA
- Development Impact Evaluation, World Bank, Washington, DC, USA
| | - Md Reazul Haque
- Department of Development Studies, University of Dhaka, Dhaka, Bangladesh
| | | | - Manzur Ahmad
- Business Administration Department, EXIM Bank Agricultural University, Chapainawabgonj, Bangladesh
| | - Hadi El-Amine
- Systems Engineering and Operations Research Department, George Mason University, Fairfax, Virginia, USA
| | - Naoru Koizumi
- Schar School of Policy and Government, George Mason University, Arlington, Virginia, USA
| |
Collapse
|
3
|
Takimoto Y. Should Physicians Be Permitted to Refuse Follow-Up Care to Patients Who Have Received an Organ Transplant Through Organ Trafficking? Transpl Int 2023; 36:11529. [PMID: 37869720 PMCID: PMC10587550 DOI: 10.3389/ti.2023.11529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2023] [Accepted: 09/25/2023] [Indexed: 10/24/2023]
Abstract
In 2018, the Istanbul Declaration stated that organ transplantation via organ trafficking is a crime. Since then, the number of medical institutions in Japan who refuse follow-up care to patients who have undergone unethical organ transplantation overseas has been gradually increasing. Deterring transplant tourism involving organ trafficking is an issue that must be addressed by the government, medical institutions, and individual physicians. The refusal of medical institutions and individual physicians to provide follow-up care after organ transplantation may challenge the idea of the incompatibility thesis; moreover, it may be ethically justified in the context of conscientious objection if it is based on the belief of deterring transplant tourism instead of punitive motives or a reluctance to support a criminal activity. However, conscientious objection based on a belief in fair transplantation care is conditional; according to the compromise approach, it is limited to particular conditions, such as that the patient's medical state does not require urgent care and that the patient is reasonably able to receive follow-up care at another institution.
Collapse
Affiliation(s)
- Yoshiyuki Takimoto
- Department of Biomedical Ethics, Faculty of Medicine, The University of Tokyo, Tokyo, Japan
| |
Collapse
|
4
|
Li MH, Siddique AB, Wilson B, Patel A, El-Amine H, Koizumi N. Identifying kidney trade networks using web scraping data. BMJ Glob Health 2022; 7:bmjgh-2022-009803. [PMID: 36113891 PMCID: PMC9486190 DOI: 10.1136/bmjgh-2022-009803] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2022] [Accepted: 08/29/2022] [Indexed: 11/23/2022] Open
Abstract
Kidney trade has been on the rise despite the domestic and international law enforcement aiming to protect the vulnerable population from potential exploitation. Regional hubs are emerging in several parts of the world including South Asia, Central America, the Middle East and East Asia. Kidney trade networks reported in these hot spots are often complex systems involving several players such as buyers, sellers and surgery countries operating across international borders so that they can bypass domestic laws in sellers and buyers’ countries. The exact patterns of the country networks are, however, largely unknown due to the lack of a systematic approach to collect the data. Most of the kidney trade information is currently available in the form of case studies, court materials and news articles or reports, and no comprehensive database exists at this time. The present study thus explored online newspaper scraping to systematically collect 10 419 news articles from 24 major English newspapers in South Asia (January 2016 to May 2019) and build transnational kidney trade networks at the country level. Additionally, this study applied text mining techniques to extract words from each news article and developed machine learning algorithms to identify kidney trade and non-kidney trade news articles. Our findings suggest that online newspaper scraping coupled with the machine learning method is a promising approach to compile such data, especially in the dire shortage of empirical data.
Collapse
Affiliation(s)
- Meng-Hao Li
- Schar School of Policy and Government, George Mason University, Arlington, Virginia, USA
| | - Abu Bakkar Siddique
- Schar School of Policy and Government, George Mason University, Arlington, Virginia, USA
| | - Brian Wilson
- Schar School of Policy and Government, George Mason University, Arlington, Virginia, USA
| | - Amit Patel
- Department of Public Policy and Public Affairs, University of Massachusetts Boston, Boston, Massachusetts, USA
| | - Hadi El-Amine
- Systems Engineering and Operations Research Department, George Mason University, Fairfax, Virginia, USA
| | - Naoru Koizumi
- Schar School of Policy and Government, George Mason University, Arlington, Virginia, USA
| |
Collapse
|
5
|
The Transplant Trolley Problem. Camb Q Healthc Ethics 2022; 31:281-284. [PMID: 35899539 DOI: 10.1017/s0963180121000980] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
6
|
An audit of surgical site infections among Omani travelers to India for spinal surgery. HEALTH POLICY OPEN 2021. [DOI: 10.1016/j.hpopen.2021.100049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
7
|
Tonkens R. The Most Good You Can Do with Your Kidneys: Effective Altruism and the Organ-Shortage Problem. THE JOURNAL OF MEDICINE AND PHILOSOPHY 2021; 46:350-376. [PMID: 34106278 DOI: 10.1093/jmp/jhab007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Effective altruism is a growing philosophical and social movement, whose members design their lives in ways aligned with doing the most good that they can do. The main focus of this paper is to explore what effective altruism has to say about the moral obligations people have to do good with their organs, in the face of an organ-shortage problem. It is argued that an effective altruism framework offers a number of valuable theoretical and practical insights relevant to ongoing debate about how to resolve the organ-shortage problem. Its recommendations constitute a plausible and promising strategy for increasing the supply of, and decreasing the demand for, human organs, in a way that protects (rather than ignores, or preys upon) the global poor. And, many of its recommendations can be implemented into policy without requiring that citizens actually become effective altruists themselves.
Collapse
Affiliation(s)
- Ryan Tonkens
- Lakehead University, Thunder Bay, Ontario, Canada
| |
Collapse
|
8
|
Viciana H, Hannikainen IR, Rodríguez-Arias D. Absolutely Right and Relatively Good: Consequentialists See Bioethical Disagreement in a Relativist Light. AJOB Empir Bioeth 2021; 12:190-205. [PMID: 33900150 DOI: 10.1080/23294515.2021.1907476] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
BACKGROUND Contemporary societies are rife with moral disagreement, resulting in recalcitrant disputes on matters of public policy. In the context of ongoing bioethical controversies, are uncompromising attitudes rooted in beliefs about the nature of moral truth? METHODS To answer this question, we conducted both exploratory and confirmatory studies, with both a convenience and a nationally representative sample (total N = 1501), investigating the link between people's beliefs about moral truth (their metaethics) and their beliefs about moral value (their normative ethics). RESULTS Across various bioethical issues (e.g., medically-assisted death, vaccine hesitancy, surrogacy, mandatory organ conscription, or genetically modified crops), consequentialist attitudes were associated with weaker beliefs in an objective moral truth. This association was not explained by domain-general reflectivity, theism, personality, normative uncertainty, or subjective knowledge. CONCLUSIONS We find a robust link between the way people characterize prescriptive disagreements and their sensibility to consequences. In addition, both societal consensus and personal conviction contribute to objectivist beliefs, but these effects appear to be asymmetric, i.e., stronger for opposition than for approval.
Collapse
Affiliation(s)
- Hugo Viciana
- Juan de la Cierva Research Fellow, MICINN.,Instituto de Filosofía, Consejo Superior de Investigaciones Científicas, Madrid, Spain
| | - Ivar R Hannikainen
- Juan de la Cierva Research Fellow, MICINN.,FiloLab-UGR Scientific Unit of Excellence, Departamento de Filosofía I, Universidad de Granada, Granada, Spain
| | - David Rodríguez-Arias
- FiloLab-UGR Scientific Unit of Excellence, Departamento de Filosofía I, Universidad de Granada, Granada, Spain
| |
Collapse
|
9
|
Albertsen A. If the Price is Right: The Ethics and Efficiency of Market Solutions to the Organ Shortage. JOURNAL OF BIOETHICAL INQUIRY 2020; 17:357-367. [PMID: 32557218 DOI: 10.1007/s11673-020-09981-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/20/2019] [Accepted: 04/23/2020] [Indexed: 05/09/2023]
Abstract
Due to the shortage of organs, it has been proposed that the ban on organ sales is lifted and a market-based procurement system introduced. This paper assesses four prominent proposals for how such a market could be arranged: unregulated current market, regulated current market, payment-for-consent futures market, and the family-reward futures market. These are assessed in terms of how applicable prominent concerns with organ sales are for each model. The concerns evaluated are that organ markets will crowd out altruistic donation, that consent to sell organs is invalid, that sellers will be harmed, and that commodification of organs will affect human relationships in a negative way. The paper concludes that the family-reward futures market fares best in this comparison but also that it provides the weakest incentive to potential buyers. There is an inverse relationship between how applicable prominent critiques are to organ market models and the increase in available organs they can be expected to provide.
Collapse
Affiliation(s)
- Andreas Albertsen
- Department of Political Science, School of Business and Social Sciences, Aarhus University, Bartholins Alle 7, 8000, Aarhus C, Denmark.
| |
Collapse
|
10
|
Gilbert F, O'Connell CD, Mladenovska T, Dodds S. Print Me an Organ? Ethical and Regulatory Issues Emerging from 3D Bioprinting in Medicine. SCIENCE AND ENGINEERING ETHICS 2018; 24:73-91. [PMID: 28185142 DOI: 10.1007/s11948-017-9874-6] [Citation(s) in RCA: 69] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/12/2016] [Accepted: 01/11/2017] [Indexed: 06/06/2023]
Abstract
Recent developments of three-dimensional printing of biomaterials (3D bioprinting) in medicine have been portrayed as demonstrating the potential to transform some medical treatments, including providing new responses to organ damage or organ failure. However, beyond the hype and before 3D bioprinted organs are ready to be transplanted into humans, several important ethical concerns and regulatory questions need to be addressed. This article starts by raising general ethical concerns associated with the use of bioprinting in medicine, then it focuses on more particular ethical issues related to experimental testing on humans, and the lack of current international regulatory directives to guide these experiments. Accordingly, this article (1) considers whether there is a limit as to what should be bioprinted in medicine; (2) examines key risks of significant harm associated with testing 3D bioprinting for humans; (3) investigates the clinical trial paradigm used to test 3D bioprinting; (4) analyses ethical questions of irreversibility, loss of treatment opportunity and replicability; (5) explores the current lack of a specific framework for the regulation and testing of 3D bioprinting treatments.
Collapse
Affiliation(s)
- Frederic Gilbert
- University of Tasmania, Hobart, Australia.
- ARC Centre of Excellence for Electromaterials Science (ACES), Wollongong, Australia.
| | - Cathal D O'Connell
- ARC Centre of Excellence for Electromaterials Science (ACES), Wollongong, Australia
- University of Wollongong, Wollongong, Australia
| | - Tajanka Mladenovska
- ARC Centre of Excellence for Electromaterials Science (ACES), Wollongong, Australia
- Department of Surgery, St. Vincent's Hospital, University of Melbourne, Melbourne, Australia
| | - Susan Dodds
- University of Tasmania, Hobart, Australia
- ARC Centre of Excellence for Electromaterials Science (ACES), Wollongong, Australia
- University of New South Wales, Sydney, Australia
| |
Collapse
|
11
|
Semrau L. Reassessing the Likely Harms to Kidney Vendors in Regulated Organ Markets. THE JOURNAL OF MEDICINE AND PHILOSOPHY 2017; 42:634-652. [DOI: 10.1093/jmp/jhx025] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023] Open
|
12
|
Mogaka JJO, Mupara L, Tsoka-Gwegweni JM. Ethical issues associated with medical tourism in Africa. JOURNAL OF MARKET ACCESS & HEALTH POLICY 2017; 5:1309770. [PMID: 28740618 PMCID: PMC5508395 DOI: 10.1080/20016689.2017.1309770] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/10/2017] [Accepted: 03/17/2017] [Indexed: 06/07/2023]
Abstract
Global disparities in medical technologies, laws, economic inequities, and social-cultural differences drive medical tourism (MT), the practice of travelling to consume healthcare that is either too delayed, unavailable, unaffordable or legally proscribed at home. Africa is simultaneously a source and destination for MT. MT however, presents a new and challenging health ethics frontier, being largely unregulated and characterized by policy contradictions, minority discrimination and conflict of interest among role-players. This article assesses the level of knowledge of MT and its associated ethical issues in Africa; it also identifies critical research gaps on the subject in the region. Exploratory design guided by Arksey and O'Malley's (2005) framework was used. Key search terms and prior determined exclusion/inclusion criteria were used to identify relevant literature sources. Fifty-seven articles met the inclusion criteria. Distributive justice, healthcare resource allocation, experimental treatments and organ transplant were the most common ethical issues of medical tourism in Africa. The dearth of robust engagement of MT and healthcare ethics, as identified through this review, calls for more rigorous research on this subject. Although the bulk of the medical tourism industry is driven by global legal disparities based on ethical considerations, little attention has been given to this subject.
Collapse
Affiliation(s)
- John J. O. Mogaka
- Discipline of Public Health Medicine, University of KwaZulu Natal, Durban, South Africa
| | - Lucia Mupara
- Discipline of Public Health Medicine, University of KwaZulu Natal, Durban, South Africa
| | | |
Collapse
|
13
|
Caulfield T, Zarzeczny A. Curbing transplant tourism: Canadian physicians and the law. CMAJ 2016; 188:935-936. [PMID: 27270121 DOI: 10.1503/cmaj.160497] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Affiliation(s)
- Timothy Caulfield
- Health Law Institute, Faculty of Law (Caulfield), University of Alberta, Edmonton, Alta.; Johnson Shoyama Graduate School of Public Policy (Zarzeczny), University of Regina, Regina, Sask.
| | - Amy Zarzeczny
- Health Law Institute, Faculty of Law (Caulfield), University of Alberta, Edmonton, Alta.; Johnson Shoyama Graduate School of Public Policy (Zarzeczny), University of Regina, Regina, Sask
| |
Collapse
|
14
|
Abstract
Organ availability for transplantation has become an increasingly complex and difficult question in health economics and ethical practice. Advances in technology have seen prolonged life expectancy, and the global push for organs creates an ever-expanding gap between supply and demand, and a significant cost in bridging that gap. This article will examine the ethical implications for the nursing profession in regard to the procurement of organs from an impoverished seller’s market, also known as ‘Transplant Tourism’. This ethical dilemma concerns itself with resource allocation, informed consent and the concepts of egalitarianism and libertarianism. Transplant Tourism is an unacceptable trespass against human dignity and rights from both a nursing and collective viewpoint. Currently, the Australian Nursing and Midwifery Council, the Royal college of Nursing Australia, The Royal College of Nursing (UK) and the American Nurses Association do not have position statements on transplant tourism, and this diminishes us as a force for change. It diminishes our role as advocates for the most marginalised in our world to have access to care and to choice and excludes us from a very contemporary real debate about the mismatch of organ demand and supply in our own communities. As a profession, we must have a voice in health policy and human rights, and according to our Code of Ethics in Australia and around the world, act to promote and protect the fundamental human right to healthcare and dignity.
Collapse
|
15
|
Caulfield T, Duijst W, Bos M, Chassis I, Codreanu I, Danovitch G, Gill J, Ivanovski N, Shin M. Trafficking in Human Beings for the Purpose of Organ Removal and the Ethical and Legal Obligations of Healthcare Providers. Transplant Direct 2016; 2:e60. [PMID: 27500253 PMCID: PMC4946496 DOI: 10.1097/txd.0000000000000566] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2015] [Accepted: 11/18/2015] [Indexed: 11/25/2022] Open
Abstract
Physicians and other health care professionals seem well placed to play a role in the monitoring and, perhaps, in the curtailment of the trafficking in human beings for the purpose of organ removal. They serve as important sources of information for patients and may have access to information that can be used to gain a greater understanding of organ trafficking networks. However, well-established legal and ethical obligations owed to their patients can create challenging policy tensions that can make it difficult to implement policy action at the level of the physician/patient. In this article, we explore the role-and legal and ethical obligations-of physicians at 3 key stages of patient interaction: the information phase, the pretransplant phase, and the posttransplant phase. Although policy challenges remain, physicians can still play a vital role by, for example, providing patients with a frank disclosure of the relevant risks and harms associated with the illegal organ trade and an honest account of the physician's own moral objections. They can also report colleagues involved in the illegal trade to an appropriate regulatory authority. Existing legal and ethical obligations likely prohibit physicians from reporting patients who have received an illegal organ. However, given the potential benefits that may accrue from the collection of more information about the illegal transactions, this is an area where legal reform should be considered.
Collapse
Affiliation(s)
- Timothy Caulfield
- Health Law Institute, University of Alberta, University of Alberta, Edmonton, Canada
| | - Wilma Duijst
- Radboud University Medical Centre, Nijmegen, The Netherlands
| | - Mike Bos
- Eurotransplant International Foundation, Leiden, The Netherlands
| | | | | | | | - John Gill
- University of British Columbia, Vancouver, BC, Canada
| | | | | |
Collapse
|
16
|
Ambagtsheer F, Van Balen LJ, Duijst-Heesters WLJM, Massey EK, Weimar W. Reporting Organ Trafficking Networks: A Survey-Based Plea to Breach the Secrecy Oath. Am J Transplant 2015; 15:1759-67. [PMID: 25873198 DOI: 10.1111/ajt.13245] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2014] [Revised: 01/23/2015] [Accepted: 01/29/2015] [Indexed: 01/25/2023]
Abstract
Patients travel worldwide to purchase kidneys. Transplant professionals can play a role in identifying kidney purchase. However, due to the tension between their rights and obligations, a lack of understanding and knowledge exists on how to prevent and report purchase. We present the results of a national survey that describes transplant professionals' experiences, attitudes, behaviors, conflicts of duties, legal knowledge and needs for guidelines toward patients who purchase kidneys abroad. Second, we clarify professionals' rights and obligations regarding organ purchase and propose actions that they can take to report purchase. Of the 100/241 (42%) professionals who treated patients who traveled to a country outside the European Union for a kidney transplant, 31 (31%) were certain that patients purchased kidneys. Sixty-five (65%) had suspicions that patients had bought kidneys. The majority reported a conflict of duties. Eighty percent reported a need for guidelines. Professionals can help prevent organ purchase by disclosing information about organ trafficking networks to law enforcement. Such disclosure can support the investigation and prosecution of networks. We offer key components for guidelines on disclosure of these networks.
Collapse
Affiliation(s)
- F Ambagtsheer
- Department of Internal Medicine, Section Nephrology and Transplantation, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
| | - L J Van Balen
- Department of Internal Medicine, Section Nephrology and Transplantation, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
| | | | - E K Massey
- Department of Internal Medicine, Section Nephrology and Transplantation, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
| | - W Weimar
- Department of Internal Medicine, Section Nephrology and Transplantation, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
| |
Collapse
|
17
|
Dalal AR. Philosophy of organ donation: Review of ethical facets. World J Transplant 2015; 5:44-51. [PMID: 26131406 PMCID: PMC4478599 DOI: 10.5500/wjt.v5.i2.44] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/21/2014] [Revised: 02/06/2015] [Accepted: 03/16/2015] [Indexed: 02/05/2023] Open
Abstract
Transplantation ethics is a philosophy that incorporates systematizing, defending and advocating concepts of right and wrong conduct related to organ donation. As the demand for organs increases, it is essential to ensure that new and innovative laws, policies and strategies of increasing organ supply are bioethical and are founded on the principles of altruism and utilitarianism. In the field of organ transplantation, role of altruism and medical ethics values are significant to the welfare of the society. This article reviews several fundamental ethical principles, prevailing organ donation consent laws, incentives and policies related to the field of transplantation. The Ethical and Policy Considerations in Organ Donation after Circulatory Determination of Death outline criteria for death and organ retrieval. Presumed consent laws prevalent mostly in European countries maintain that the default choice of an individual would be to donate organs unless opted otherwise. Explicit consent laws require organ donation to be proactively affirmed with state registries. The Declaration of Istanbul outlines principles against organ trafficking and transplant tourism. World Health Organization's Guiding Principles on Human Cell, Tissue and Organ Transplantation aim at ensuring transparency in organ procurement and allocation. The ethics of financial incentives and non-financial incentives such as incorporation of non-medical criteria in organ priority allocation have also been reviewed in detail.
Collapse
|
18
|
Testa G, Siegler M. Increasing the supply of kidneys for transplantation by making living donors the preferred source of donor kidneys. Medicine (Baltimore) 2014; 93:e318. [PMID: 25546677 PMCID: PMC4602590 DOI: 10.1097/md.0000000000000318] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
At the present time, increasing the use of living donors offers the best solution to the organ shortage problem. The clinical questions raised when the first living donor kidney transplant was performed, involving donor risk, informed consent, donor protection, and organ quality, have been largely answered. We strongly encourage a wider utilization of living donation and recommend that living donation, rather than deceased donation, become the first choice for kidney transplantation. We believe that it is ethically sound to have living kidney donation as the primary source for organs when the mortality and morbidity risks to the donor are known and kept extremely low, when the donor is properly informed and protected from coercion, and when accepted national and local guidelines for living donation are followed.
Collapse
Affiliation(s)
- Giuliano Testa
- From The Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center at Dallas (GT); MacLean Center for Clinical Medical Ethics, The University of Chicago (MS)
| | | |
Collapse
|
19
|
Abstract
This paper reflects on the relationship between theory and practice in bioethics, by using various concepts drawn from debates on innovation in healthcare research--in particular debates around how best to connect up blue skies 'basic' research with practical innovations that can improve human lives. It argues that it is a mistake to assume that the most difficult and important questions in bioethics are the most abstract ones, and also a mistake to assume that getting clear about abstract cases will automatically be of much help in getting clear about more complex cases. It replaces this implicitly linear model with a more complex one that draws on the idea of translational research in healthcare. On the translational model, there is a continuum of cases from the most simple and abstract (thought experiments) to the most concrete and complex (real world cases). Insights need to travel in both directions along this continuum--from the more abstract to the more concrete and from the more concrete to the more abstract. The paper maps out some difficulties in moving from simpler to more complex cases, and in doing so makes recommendations about the future of bioethics.
Collapse
Affiliation(s)
- James Wilson
- Department of Philosophy, University College London, Gower Street, London, WC1E 6BT UK
| |
Collapse
|
20
|
|
21
|
Affiliation(s)
- I Glenn Cohen
- a Harvard Law School and Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
| |
Collapse
|
22
|
Hughes JM, Wilson ME. The globalization of healthcare: implications of medical tourism for the infectious disease clinician. Clin Infect Dis 2013; 57:1752-9. [PMID: 23943826 PMCID: PMC7107947 DOI: 10.1093/cid/cit540] [Citation(s) in RCA: 64] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2013] [Accepted: 08/02/2013] [Indexed: 12/19/2022] Open
Abstract
Travel abroad for healthcare has increased rapidly; interventions include organ transplant; cardiac surgery; reproductive care; and joint, cosmetic, and dental procedures. Individuals who receive medical care abroad are a vulnerable, sentinel population, who sample the local environment and can carry home unusual and resistant infections, documented in many reports. Medical tourists are at risk for hospital-associated and procedure-related infections as well as for locally endemic infections. Patients may not volunteer details about care abroad, so clinicians must inquire about medical procedures abroad as well as recent travel. Special infection control measures may be warranted. Healthcare abroad is associated with diverse financial, legal, ethical, and health-related issues. We focus on problems the infectious disease clinician may encounter and provide a framework for evaluating returned medical tourists with suspected infections. A better system is needed to ensure broad access to high-quality health services, continuity of care, and surveillance for complications.
Collapse
Affiliation(s)
- James M. Hughes
- Correspondence: Lin H. Chen, MD, Division of Infectious Diseases, Mount Auburn Hospital, 330 Mount Auburn St, Cambridge, MA 02238 ()
| | | |
Collapse
|